Helicase-primase inhibitors as next-generation anti-HSV agents: from current clinical status to structure-activity relationships and patent coverage
{{output}}
Introduction: Helicase-primase is an interesting target for small-molecule therapy of orthoherpesviruses in general and in particular herpes simplex virus (HSV) and varicella zoster virus (VZV) infections. With amenamevir already... ...
